Flx-787-odt (orally disintegrating tablet)    (DrugBank: -)

1 disease
IDDisease name (Link within this page)Number of trials
10Charcot-Marie-Tooth disease1

10. Charcot-Marie-Tooth disease    [ 31 clinical trials,   38 drugs,   (DrugBank: 9 drugs),   11 drug target genes,   14 drug target pathways]
Searched query = "Charcot-Marie-Tooth disease", "CMT"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.
1 / 31 trial found
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT03254199
(ClinicalTrials.gov)
October 16, 201716/8/2017A Study to Assess the Safety and Effectiveness of FLX-787 in Subjects With Charcot-Marie-Tooth Disease Experiencing Muscle Cramps.A Randomized, Double-Blind, Controlled, Parallel Group Study to Evaluate the Efficacy and Safety of FLX-787-ODT for Treatment of Muscle Cramps in Adult Subjects With Charcot-Marie-Tooth DiseaseCharcot-Marie-Tooth DiseaseDrug: FLX-787-ODT (orally disintegrating tablet);Drug: Placebo ODTFlex Pharma, Inc.NULLTerminated18 YearsN/AAll27Phase 2United States